Compare EC Healthcare with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-21.74%
0%
-21.74%
6 Months
-26.03%
0%
-26.03%
1 Year
-62.76%
0%
-62.76%
2 Years
-88.49%
0%
-88.49%
3 Years
-93.2%
0%
-93.2%
4 Years
-95.7%
0%
-95.7%
5 Years
-87.26%
0%
-87.26%
EC Healthcare for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
19.75%
EBIT Growth (5y)
-165.07%
EBIT to Interest (avg)
3.47
Debt to EBITDA (avg)
0.24
Net Debt to Equity (avg)
-0.02
Sales to Capital Employed (avg)
1.27
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
9.95%
ROE (avg)
9.02%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
0.54
EV to EBIT
34.06
EV to EBITDA
1.39
EV to Capital Employed
0.52
EV to Sales
0.22
PEG Ratio
0.19
Dividend Yield
1.23%
ROCE (Latest)
1.54%
ROE (Latest)
5.52%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Mar 2024
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
4,140.20
4,211.00
-1.68%
Operating Profit (PBDIT) excl Other Income
659.60
732.80
-9.99%
Interest
92.90
100.80
-7.84%
Exceptional Items
-246.80
-50.40
-389.68%
Consolidate Net Profit
-111.90
15.70
-812.74%
Operating Profit Margin (Excl OI)
6.90%
25.50%
-1.86%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is -1.68% vs 8.66% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is -812.74% vs -85.33% in Mar 2024
About EC Healthcare 
EC Healthcare
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






